When is the Killing Floor 3 release date? It's been nearly seven years since Killing Floor 2 was released, bringing Horzine Biotech's Zeds to a more single-player friendly format following the 6 ...

Portage Biotech's PORT-7 showed >90% tumor growth inhibition with anti-PD1 combo in a murine mesothelioma model. PORT-7 single-agent activity outperformed anti-PD1 treatment alone; first-in-human ...

China is moving fast to dominate biotechnology, and the U.S. risks falling behind permanently unless it takes action over the next three years, a congressional commission said. Congress should ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on its website, the company said the decision followed months of efforts ...

Biotechnology offers a scalable alternative, but realizing its full potential requires commitment from governments and space agencies. By harnessing biological processes such as microbial and ...

In this article, we will be taking a look at the 7 most profitable biotech stocks to buy right now. With improved market conditions, innovative breakthroughs, and more investor interest ...

PORT-7 shows >90% tumor growth inhibition in mesothelioma models when combined with an anti-PD1 antibody. Portage plans a first-in-human trial for PORT-7 and aims to combine PORT-6 and PORT-7 to ...

For Rituja Suraj Chavan, Managing Director of Valient Biotech Pvt Ltd, starting a company was never just about business—it was about making a difference. The company was founded with a dual ...

Biotech companies are innovators, which could translate into growth for your portfolio. It’s important to think long term and pay particular attention to a biotech’s pipeline -- today’s out ...

Things are heating up in the biotechnology space, with a flurry of recent initial public offerings and some notable insider purchases of the past week or so. Officers, directors, and beneficial ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

WITH DIFFERENT BACKGROUNDS FROM ALL OVER THE WORLD... TO NETWORK AND TALK ABOUT THE EVOLUTION OF BIOTECHNOLOGY. "WE ARE ALL CHILDREN FROM FARMWORKERS FROM THE SALINAS VALLEY. PART OF THE GLOBAL ...